Author: Dorron Blumberg

Jackson Health System Celebrates The Grand Opening of New Urgent Care Center in Doral

Jackson Health System celebrated the grand opening of a new urgent care center, the fourth one in a network of urgent care centers announced under the $1.5 Jackson Miracle Building Program. A ribbon-cutting ceremony was held at 10 a.m., Wednesday, July 25. Opening remarks were presnted by: Carlos A. Migoya, President & CEO, Jackson Health System, Joe Arriola, President, Public Health Trust and Dr. Henri Ford, Dean and Chief Academic Officer, University of Miami Miller School of Medicine UHealth Jackson Urgent Care staff. After the ribbon cutting, at 12:30pm  the facility was re-opened to patients.

Read More

ChenMed and Turner Impact Capital Expand Investments in New

Dedicated Senior Medical Centers to Help Aging Floridians

Turner Healthcare Facilities Fund fuels vital growth for leading primary care provider
ChenMed, a leading primary care provider, and Turner Impact Capital, one of the nation’s largest social impact investment firms, are expanding their relationship by opening several new Dedicated Senior Medical Centers in Florida this year. The new facilities will bring affordable, concierge-style medical care to thousands of low- and moderate-income Bradenton, Jacksonville and Tampa Bay seniors.
The rapid expansion of Dedicated centers builds on last year’s successful opening of a Dedicated Senior Medical Center in St. Petersburg, Fla., developed by Turner Impact Capital’s Turner Healthcare Facilities Fund. Growth of that Dedicated practice has exceeded all expectations – benefitting the community, ChenMed, and Turner Impact Capital investors.
The ongoing partnership between ChenMed and Turner Impact Capital enabled three Dedicated primary care practices to open doors to patients on July 2 in Bradenton and Jacksonville. A fourth Dedicated center developed independently also opened on July 2 in Jacksonville. Turner Impact Capital investments will be instrumental in helping ChenMed establish two additional Dedicated centers in Tampa Bay this fall.

Read More

Next-generation ALS drug silences inherited form of the disease in animal models

NIH-funded preclinical study suggests drug may be ready for early stage clinical trials.
     
NIH-funded researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results, published in the Journal of Clinical Investigation, suggest the newer version of the drug may be effective at treating an inherited form of the disease caused by mutations in SOD1. Currently, the drug is being tested in an ALS clinical trial (NCT02623699).

Read More

Senate Committee Approves Bill Allowing Pharmacists to Tell Patients That a Drug is Cheaper if They Use Cash Instead of Insurance

Also approves bill to encourage research to help treat sickle cell disease
 
The Senate health committee today approved four important pieces of legislation, including a bill that will help Americans who are struggling to afford their prescriptions, and a bill that will encourage research to help treat sickle cell disease.
 
“Many Americans struggle to afford their prescriptions,” Chairman Lamar Alexander (R-Tenn.) said. “Senator Collins’ bill ends ‘gag rules’ that prevent a pharmacist from telling a patient that a prescription is cheaper if the patient pays cash instead of using his or her insurance. The Committee has also held four bipartisan hearings on the high cost patients pay for prescription drugs, most recently to hear from Secretary Azar on the President’s blueprint to reduce the costs Americans pay for prescription drugs. 

Read More